Clinical endpoint
Clinical Endpoint[edit | edit source]
A clinical endpoint is a term used in clinical trials to refer to a measure that reflects how a patient feels, functions, or survives. Clinical endpoints are critical in determining the efficacy and safety of a new treatment or intervention.
Types of Clinical Endpoints[edit | edit source]
Clinical endpoints can be classified into several types:
- Primary Endpoint: The main result that is measured at the end of a study to see if the treatment worked (e.g., survival rate, reduction in symptoms).
- Secondary Endpoint: Additional effects of the treatment that are also of interest but are not the main focus of the study (e.g., quality of life, side effects).
- Surrogate Endpoint: A substitute for a clinical endpoint that measures a biological or physical sign that is expected to predict clinical benefit (e.g., blood pressure, cholesterol levels).
Importance in Clinical Trials[edit | edit source]
Clinical endpoints are essential for the following reasons:
- They provide a clear and measurable outcome to assess the effectiveness of a treatment.
- They help in the regulatory approval process by providing evidence of the treatment's benefits.
- They guide healthcare providers in making informed decisions about patient care.
Selection of Clinical Endpoints[edit | edit source]
The selection of appropriate clinical endpoints is crucial and depends on several factors:
- The nature of the disease or condition being studied.
- The expected effect of the treatment.
- The feasibility of measuring the endpoint accurately and reliably.
Examples of Clinical Endpoints[edit | edit source]
- In oncology trials, common clinical endpoints include overall survival and progression-free survival.
- In cardiology trials, endpoints may include myocardial infarction and stroke.
- In infectious disease trials, endpoints often include infection rate and mortality rate.
Challenges in Using Clinical Endpoints[edit | edit source]
Some challenges associated with clinical endpoints include:
- Variability in how endpoints are measured and reported.
- The need for long-term follow-up to observe certain endpoints.
- Ethical considerations in withholding treatment to measure endpoints.
Related Pages[edit | edit source]
- Clinical trial
- Surrogate endpoint
- Primary endpoint
- Secondary endpoint
- Overall survival
- Progression-free survival
- Myocardial infarction
- Stroke
- Infection rate
- Mortality rate
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD